MCKESSON CORP

Listed Company

MCKCIK 0000927653NYSELarge AcceleratedWholesale-Drugs, Proprietaries & Druggists' SundriesDelawareFY ends Mar 31

Period

FY 2026

Revenue

$403.43B

Net Income

$4.76B

Total Assets

$82.32B

Equity

$-2.17B

Shares Out

120.20M

Op. Cash Flow

$6.16B

MCK$841.39+18.42% · past yearDBEQ Basic

Daily closing prices

Business

McKesson Corporation is a diversified healthcare distributor providing branded, generic, specialty, and over-the-counter pharmaceutical drugs, medical-surgical supplies, and related products across North America. The company operates four reportable segments: North American Pharmaceutical (U.S. and Canadian distribution and pharmacy solutions), Oncology & Multispecialty (specialty drug distribution and clinical services), Prescription Technology Solutions (medication-access platforms), and Medical-Surgical Solutions (supplies for non-acute settings). McKesson serves pharmacies, hospitals, healthcare providers, manufacturers, and patients.

Summary from 10-K filed 2026-05-08

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31
Revenues	403,430	359,051	308,951	276,711	263,966
Cost of sales	−388,880	−345,728	−296,123	−264,353	−250,836
Gross profit	14,550	13,323	12,828	12,358	13,130
Selling, distribution, general, and administrative expenses	−8,096	−8,507	−8,657	−7,776	−10,537
Claims and litigation charges, net	3	−108	−147	8	−274
Restructuring, impairment, and related charges, net	−245	−286	−115	−209	−281
Total operating expenses	−8,338	−8,901	−8,919	−7,977	−11,092
Operating income	6,212	4,422	3,909	4,381	2,038
Other income, net	236	202	132	497	259
Interest expense	−247	−265	−252	−248	—
Income before income taxes	6,201	4,359	3,789	—	—
Income tax expense	−1,102	−878	−629	−905	−636
Net income	5,099	3,481	3,160	3,722	1,287
Net income attributable to noncontrolling interests	−337	−186	−158	−162	−173
Net income attributable to McKesson Corporation	4,762	3,295	3,002	3,560	1,114
Diluted (in dollars per share)	38.38	25.72	22.39	25.03	7.23
Basic (in dollars per share)	38.55	25.86	22.54	25.23	7.32
Diluted (in shares)	124	128	134	142	154
Basic (in shares)	124	127	133	141	152

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31
Cash and cash equivalents	3,975	5,691	4,583	4,678	3,532
Receivables, net	27,985	25,643	21,622	19,410	18,583
Inventories, net	24,200	23,000	21,100	19,700	18,700
Prepaid expenses and other	1,043	1,063	626	513	898
Total current assets	57,210	55,398	47,970	44,292	46,231
Property, plant, and equipment, net	2,668	2,502	2,316	2,177	2,092
Operating lease right-of-use assets	2,058	1,782	1,729	1,635	1,548
Goodwill	11,316	10,022	10,132	9,947	9,451
Intangible assets, net	4,079	1,464	2,110	2,277	2,059
Other non-current assets	4,992	3,972	3,186	1,992	1,917
Total assets	82,323	75,140	67,443	62,320	63,298
Drafts and accounts payable	59,973	55,330	47,097	42,490	38,086
Current portion of long-term debt	1,300	1,200	50	968	799
Current portion of operating lease liabilities	287	258	295	299	297
Other accrued liabilities	5,490	4,825	4,915	4,200	4,543
Total current liabilities	67,017	61,604	52,357	47,957	48,466
Long-term debt	5,259	4,463	5,579	4,626	5,080
Long-term deferred tax liabilities	1,330	1,029	917	1,387	1,418
Long-term operating lease liabilities	1,801	1,478	1,466	1,402	1,366
Long-term litigation liabilities	5,091	5,601	6,113	6,625	7,220
Other non-current liabilities	2,659	2,659	2,610	1,813	1,540
Commitments and contingent liabilities (Note 17)	—	—	—	—	—
Redeemable noncontrolling interests	943	0	—	—	0
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding	0	0	0	0	0
Common stock, $0.01 par value, 800 shares authorized, 280 and 279 shares issued at March 31, 2026 and 2025, respectively	3	3	3	3	2
Additional paid-in capital	8,284	8,373	8,048	7,747	7,275
Retained earnings	22,291	17,921	14,978	12,295	9,030
Accumulated other comprehensive loss	−745	−932	−881	−905	−1,534
Treasury shares, at cost, 160 and 154 shares at March 31, 2026 and 2025, respectively	−32,005	−27,439	−24,119	−20,997	−17,045
Total McKesson Corporation stockholders deficit	−2,172	−2,074	−1,971	−1,857	−2,272
Noncontrolling interests	395	380	372	367	480
Total deficit	−1,777	−1,694	−1,599	−1,490	−1,792
Total liabilities, redeemable noncontrolling interests, and deficit	82,323	75,140	67,443	62,320	63,298

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31
Depreciation	256	242	253	248	279
Amortization	473	394	382	360	481
Long-lived asset impairment charges	55	98	43	72	175
Deferred taxes	230	−110	−603	−20	34
Charges (credits) associated with last-in, first-out inventory method	−210	82	−157	1	−23
Non-cash operating lease expense	261	245	228	249	241
Loss (gain) from sales of businesses and investments	−573	485	−17	−211	−132
Provision for bad debts	100	−130	819	45	29
Other non-cash items	302	424	233	253	472
Receivables	−1,999	−3,935	−2,954	−1,082	−1,843
Inventories	−1,082	−2,270	−1,294	−1,259	−1,169
Drafts and accounts payable	4,317	8,301	4,587	3,788	2,802
Operating lease liabilities	−270	−404	−339	−338	−356
Taxes	−339	−136	331	363	243
Litigation liabilities	−684	−401	−395	−1,088	199
Other	219	−281	37	56	206
Net cash provided by operating activities	6,155	6,085	4,314	5,159	4,434
Payments for property, plant, and equipment	−436	−537	−431	−390	−388
Capitalized software expenditures	−309	−322	−256	−168	−147
Acquisitions, net of cash, cash equivalents, and restricted cash acquired	−3,416	−24	−272	−867	−6
Proceeds from sales of businesses and investments, net	830	179	47	1,077	578
Other	−101	−29	−160	−194	−126
Net cash used in investing activities	−3,432	−733	−1,072	−542	−89
Proceeds from short-term borrowings	9,247	15,086	19,964	8,450	11,192
Repayments of short-term borrowings	−9,247	−15,086	−19,964	−8,450	−11,192
Proceeds from issuances of long-term debt	1,990	498	991	997	498
Repayments of long-term debt	−1,207	−519	−288	−1,274	−1,648
Purchase of U.S. government obligations for the satisfaction and discharge of long-term debt	0	0	−647	0	0
Issuances	89	101	116	163	220
Share repurchases	−4,750	−3,146	−3,025	−3,638	−3,516
Dividends paid	−381	−345	−314	−292	−277
Other	−372	−554	−175	−324	−383
Net cash used in financing activities	−4,631	−3,965	−3,342	−4,368	−6,321
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	20	−16	6	25	55
Net increase (decrease) in cash, cash equivalents, and restricted cash	−1,888	1,371	−94	744	−2,461
Interest, net	212	273	234	224	186
Income taxes, net of refunds	1,211	1,124	901	562	359

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is MCKESSON CORP's CIK number?

MCKESSON CORP's SEC CIK number is 0000927653 (927653). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find MCKESSON CORP's SEC filings?

All of MCKESSON CORP's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did MCKESSON CORP last report earnings?

MCKESSON CORP (MCK) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0000927653-26-000066). This is MCKESSON CORP's most recent earnings filing of record — not a forecast of its next earnings date.

What is MCKESSON CORP's most recent earnings 8-K?

MCKESSON CORP's latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0000927653-26-000066. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View MCKESSON CORP's latest earnings 8-K →
Look up any company's CIK number →